IGF-1 DES
A muscle-growth compound that works more on the local muscle than the whole body. A truncated IGF-1 variant (missing the first 3 amino acids) that acts more locally than IGF-1 LR3, with shorter duration and (in theory) less systemic exposure.
IGF-1 DES: A muscle-growth compound that works more on the local muscle than the whole body. A truncated IGF-1 variant (missing the first 3 amino acids) that acts more locally than IGF-1 LR3, with shorter duration and (in theory) less systemic exposure. IGF-1 DES is a shorter version of IGF-1 LR3.
IGF-1 DES is a shorter version of IGF-1 LR3. It works more locally (near the injection site) and clears faster, which (in theory) means less systemic side effect exposure than LR3. Used by lifters for site-specific muscle anabolism.
Not FDA approved. Mecasermin (Increlex) covers IGF-1 generally; DES variant specifically is not approved.
FDA flagged as significant safety risk; restricted from compounding pharmacies.
Not prescribed in conventional medicine.
Who it's for
- →Users wanting localized muscle anabolism without LR3-level systemic exposure
- →Site-specific injection users
- →Short anabolism windows
What to expect
- Week 1
Pumps and fullness in trained muscle.
- Week 4
Site-specific tightness near worked muscle. Cycle endpoint, stop.
- Week 8
Off-cycle. Reassess.
Looking at IGF-1 DES? Your next 3 steps
- 1Work out your exact dose
Vial size + BAC water turns into the exact units to draw for IGF-1 DES.
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account saves your stack; membership adds the stack-aware AI Coach.
Create free account →
How it works (mechanism)
Truncated IGF-1 missing the first 3 amino acids. Binds the IGF-1 receptor with normal affinity but has reduced binding to IGFBPs in some tissues. Shorter duration than LR3, often used for site-specific muscle effects.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Active malignancy
- ⚠Diabetic retinopathy
- ⚠Pregnancy / nursing
Bloodwork to monitor
- • Fasting glucose every 2 weeks
- • IGF-1 baseline
Common mistakes
- • Treating it as IGF-1 LR3 equivalent (different kinetics)
- • Running longer than 4 weeks
- • Dosing fasted (hypoglycemia)
Drug & supplement interactions
- ⚠Insulin: hypoglycemia risk (less than LR3 but real)
- ⚠Eat near dose; avoid fasting protocols
New to IGF-1 DES? Grab the starter checklist.
Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if IGF-1 DES changes legal status. No account needed.
No spam. No selling your email. Just the checklist and the occasional reclassification alert.
Ask the Coach anything about IGF-1 DES or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Get the Coach, $7.99/mo →Frequently asked
What is IGF-1 DES?+
Is IGF-1 DES FDA approved?+
Is IGF-1 DES legal?+
Is IGF-1 DES banned by WADA?+
Are you still natty after taking IGF-1 DES?+
Do doctors prescribe IGF-1 DES?+
What's the typical dose of IGF-1 DES?+
What are the side effects of IGF-1 DES?+
How long until IGF-1 DES starts working?+
What can you stack with IGF-1 DES?+
Where do people get IGF-1 DES?+
IGF-1 DES vs IGF-1 LR3, which is better?+
Head-to-head with IGF-1 DES
More in GH-axis
Recombinant human growth hormone, the protein itself, not a peptide that nudges your body to make more. Highest legal-risk compound in this catalog.
Oral ghrelin mimetic. Bumps GH and IGF-1 without injections. Strong appetite stimulation is the trade-off.
Bumps your natural growth-hormone pulses without hitting cortisol or prolactin. A selective GH secretagogue.
Pairs with Ipamorelin to amplify your natural growth-hormone pulses. A GHRH analog whose 'no-DAC' version stays short-acting on purpose.